Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study

• Yusuke Sakaguchi,

  Affiliation Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka, 565-0871, Japan

  ⨯
• Naohiko Fujii,

  Affiliation Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan

  ⨯
• Tatsuya Shoji,

  Affiliation Department of Kidney Disease and Hypertension, Osaka General Medical Center, 3-1-56 Bandaihigashi Sumiyoshi-ku, Osaka, 558-8558, Japan

  ⨯
• Terumasa Hayashi,

  Affiliation Department of Kidney Disease and Hypertension, Osaka General Medical Center, 3-1-56 Bandaihigashi Sumiyoshi-ku, Osaka, 558-8558, Japan

  ⨯
• Hiromi Rakugi,

  Affiliation Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka, 565-0871, Japan

  ⨯
• Kunitoshi Iseki,

  Affiliation Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan

  ⨯
• Yoshiharu Tsubakihara,

  Affiliation Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan

  ⨯
• Yoshitaka Isaka ,

  * E-mail: isaka@kid.med.osaka-u.ac.jp

  Affiliation Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka, 565-0871, Japan

  ⨯
• the Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy